Description
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
| Product Unit Size | Cost | Quantity | Stock |
|---|
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
| Cas No. | 1170354-22-9 |
|---|---|
| Purity | ≥95% |
| Formula | C28H22F2O6 |
| Formula Wt. | 492.47 |
| Chemical Name | (1E,6E)-1,7-bis-(4-hydroxy-3-methosyphenyl) hepta-1,6-diene [4(3,4-difluorobenzaldehyde)]-3,5-dione |
| IUPAC Name | (1E,6E)-4-[(3,4-difluorophenyl)methylidene]-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione |
| Synonym | Difluorobenzocurcumin, 3,4-Difluorobenzocurcumin, CDF |
| Melting Point | 214-217°C |
| Solubility | DMSO, 110mg/mL |
| Appearance | Bright Yellow Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures | |
Okuda KS, Ng MF, Ruslan NF, et al. 3,4-Difluorobenzocurcumin inhibits Vegfc-Vegfr3-Erk signalling to block developmental lymphangiogenesis in zebrafish. Pharmaceuticals (Basel). 2021 Jun 26;14(7):614. PMID: 34206901.
Endogenous neuropeptide, involved in nociceptio...
beta-catenin inhibitor
Peptide, protease substrate.
Saponin found in Dioscorea; Na+/K+ ATPase and C...
Isoflavonoid found in Glycyrrhiza; GABA-A posit...
Mixture of pyrantel, a thiophene, and pamoic ac...
Phytoestrogen, isoflavone found in various plan...
Nucleoside (thymidine) analog; DNA chain termin...
Potential voltage-gated Na+ channel blocker.
Chloramphenicol derivative; protein translation...
Tetracycline; protein translation inhibitor.
Non-depolarizing NMJ blocker; nAChR antagonist....
Synthesis impurity
Inhibitor of ALK2, ALK3, ALK6, and AMPK.
Fast skeletal muscle troponin complex activator...
Mycotoxin produced by various fungi including t...
Cyclic depsipeptide is a secondary metabolite i...
EGFR inhibitor.
TLR4 inhibitor.
Triazolothienodiazepine; BRD inhibitor.